🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hello #PathTwitter and my fellow #PathMatch2023 applicants. I am an experienced pathologist from Turkey, and now a research scientist MSK Department of Pathology & Laboratory Medicine. Finally, I submitted #ERAS and I am ready for the interview season. Wish everyone best of luck!!

Mucinous cystic neoplasm (#MCN) is not specific to the #pancreas. It is seen in the #liver, too. Ovarian-type stroma is your clue. When in doubt, PR IHC would be helpful. Make sure to check if there is HGD or associated invasive carcinoma. This example only has LGD. @PathTwitter

Acinar Cystic Transformation of the Pancreas: a Verona's legacy -Controversial entity first described in Verona and in a few other centers 20 years ago -Now the largest series in the literature, with NGS analysis The American Journal of Surgical Pathology journals.lww.com/ajsp/Abstract/…

Many thanks to all institutions supporting my home country #Turkey & our neighbors #Syria in this devastating earthquake and I hope my institution Memorial Sloan Kettering Cancer Center joins UCLA Health Stanford Medicine NYU Langone Health and many others in these exemplary efforts

Our research on EBV associated Carcinomas of the Ampulla was just presented by Kerem Ozcan, MD 🤩 at USCAP #USCAP2023 #USCAP23 🎉🎉🎉

Now at the #USCAP2023 #GUpath platform session, Dr Merve Basar @toprakdeniz23 is presenting the clinical, molecular, and #ihcpath profiles of the Nested Subtype of Urothelial Carcinoma🎉🎉🎉 USCAP #USCAP23 Gamze Gokturk Ozcan, MD @mindtheflights Hikmat Al Ahmadie 👏🏻

Wednesday PM Poster Board #115 #USCAP2023 Dr. Kerem Ozcan MSK Department of Pathology & Laboratory Medicine presents: “Well Differentiated Neuroendocrine Tumors (WDNETs) of the Ampulla, with Glandular Growth Pattern and Psammoma Bodies (Somatostatinomas): Analysis of 65 Cases” #pbpath Pancreatobiliary Pathology Society

Wednesday PM Poster Board #118 #USCAP2023 Dr. Hulya Ozcan Hulya Sahin Ozkan MSK Department of Pathology & Laboratory Medicine presents: “Diagnostic Value of Newly Described Markers in Pancreatic Solid Cellular Neoplasms” #pbpath Pancreatobiliary Pathology Society

Great teamwork on #Acinar Cystic Transformation of the #Pancreas:... : The American Journal of Surgical Pathology journals.lww.com/ajsp/Abstract/… Claudio Luchini Kerem Ozcan, MD Seung-Mo Hong Giovanni Marchegiani Volkan Adsay

Do you s/o #intraductal #papillary #neoplasms of the #bileducts (#IPN)? Then, check out our new paper documenting everything you want to know about these tumors👇 pubmed.ncbi.nlm.nih.gov/36821179/ Rhonda Yantiss Pelin Bağcı Serdar Balcı Vinod BalachandranMD Volkan Adsay Arch Pathol Lab Med

Check out our most recent review on Early Cancerous Lesions of the #Pancreas and #Ampulla: Current Concepts ... sciencedirect.com/science/articl… Volkan Adsay #intraductal #preinvasive #IPMN #ITPN #IOPN #IAPN

Pancreas pathology platform session was very exciting with outstanding presentations including by Dr Tarcan on Oncocytic #PanNETs with aggressive features! Congratulations Dr. Tarcan. We are very proud of you #USCAP2024 Kerem Ozcan, MD Volkan Adsay

Post platform celebrations 🎉 Next generation of Turkish pathologists is amazing! #USCAP2024 Volkan Adsay Erdem Kombak (Eddy) Kerem Ozcan, MD Gamze Gokturk Ozcan, MD Berk Kaan Aktas, MD

Please join us on Wednesday, October 16th at 11 am ET for the ISIMM Web monthly webinar. Our President, Megan Troxell, will present "The Crucial Role of IHC in Papillary Breast Neoplasms." Register here: us02web.zoom.us/webinar/regist… Share far and wide!

Check out Henry Ford Pathology Residency X & instagram accounts. Happy #MatchDay #pathmatch25 #pathtwitter

It’s official! Meet our Pathology Residency Class of 2025!! #PathMatch2025 #HFHPathology #HFHPathologyResidency #HFHPath #PathMatch25 #PathMatch2025 #pathmatch #LearnLeadBelong #pathtwitter

‼️Divergent histology in bladder cancer impacts outcomes and genomics. ‼️In 3052 RC patients, UCAH subtypes (plasmacytoid, micropapillary, sarcomatoid) showed worse survival. 🎯Genomic targets: ERBB2 (micropapillary), FGFR3 (nested/squamous), PTEN (sarcomatoid).

I'm delighted to share that the recording of Dr. Dabbs' ISIMM Web webinar has been added to our website: isimm.org/2025/07/05/fro… I'm also sharing several #wallhangers from the webinar and a link to the preprint of the HER2 CASI Study (1/2) papers.ssrn.com/sol3/papers.cf…

🚨 Save the Date! 🚨 Join us for Frontiers in Gastrointestinal and Hepatobiliary Pathology 2025, happening September 27–28 at the Klarman Auditorium, BIDMC West Campus, Boston, MA — available in person and virtually! 🧠 Two days of high-impact learning, case-based discussions,